Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Salutsantjoan     Gmail     Dropbox     Instagram     Google Drive     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon


My photo
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com




Friday, March 15, 2013


ACC: Digoxin Drops HF Admissions
By Crystal Phend, Senior Staff Writer, MedPage Today
Published: March 14, 2013 - Reviewed by Zalman s. Agus, MD; Emeritus Professor, Perelman School of Medicine at the University of Pennsylvania

SAN FRANCISCO -- "Digoxin could be part of the solution to high hospitalization rates in heart failure, researchers suggested in a subanalysis of the DIG trial.
The 30-day all-cause hospital admission rate fell to 5.4% with digoxin compared with 8.1% with placebo among Medicare-age patients with heart failure (P=0.002), Ali Ahmed, MD, MPH, of the VA Medical Center and University of Alabama at Birmingham, and colleagues found.
That 34% relative reduction could be crucial for hospitals' bottom line now that Medicare reduces reimbursement for facilities whose 30-day readmissions are too high, Ahmed reported here at the American College of Cardiology meeting.
The results with digoxin persisted without a price to pay in later readmissions, deaths, or other events, he added at the late-breaking clinical trial session. Results were released simultaneously online in the American Journal of Medicine."

Action Points

  • In a post-hoc subanalysis of the DIG trial, digoxin reduced the risk of 30-day hospital admission in ambulatory older adults with chronic systolic heart failure receiving ACE inhibitors and diuretics.
  • It is not known if similar results could be replicated in contemporary older heart failure patients as management of congestive failure has changed and is managed much more aggressively today.